| Title | Expert Review of Pharmacoeconomics and Outcomes Research |
| Abbreviation | Expert Rev. Pharmacoeconomics Outcomes Res. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2) |
| h-index | 60 |
| Overall Rank/Ranking | 8649 |
| SCImago Journal Rank (SJR) | 0.596 |
| Impact Score | 2.48 |
| Publisher | Taylor and Francis Ltd. |
| Country | United Kingdom |
| ISSN | 14737167, 17448379 |
| Best Quartile | Q2 |
| Coverage History | 2001-2022 |
Expert Review of Pharmacoeconomics and Outcomes Research is a journal covering the technologies/fields/categories related to Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2). It is published by Taylor and Francis Ltd.. The overall rank of Expert Review of Pharmacoeconomics and Outcomes Research is 8649. According to SCImago Journal Rank (SJR), this journal is ranked 0.596. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 60. The best quartile for this journal is Q2.
The ISSN of Expert Review of Pharmacoeconomics and Outcomes Research journal is 14737167, 17448379. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Expert Review of Pharmacoeconomics and Outcomes Research is cited by a total of 641 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Expert Review of Pharmacoeconomics and Outcomes Research is 2.48, which is computed in 2023 as per its definition. Expert Review of Pharmacoeconomics and Outcomes Research IF is increased by a factor of 0.4 and approximate percentage change is 19.23% when compared to preceding year 2021, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Expert Review of Pharmacoeconomics and Outcomes Research is 2.48. If the same upward trend persists, Impact IF may rise in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 2.48 |
| 2021 | 2.08 |
| 2020 | 1.87 |
| 2019 | 2.11 |
| 2018 | 1.71 |
| 2017 | 1.65 |
| 2016 | 1.61 |
| 2015 | 1.80 |
| 2014 | 1.96 |
Expert Review of Pharmacoeconomics and Outcomes Research has an h-index of 60. It means 60 articles of this journal have more than 60 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Expert Review of Pharmacoeconomics and Outcomes Research is 14737167, 17448379. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Expert Review of Pharmacoeconomics and Outcomes Research is 8649. According to SCImago Journal Rank (SJR), this journal is ranked 0.596. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.596 |
| 2021 | 0.552 |
| 2020 | 0.670 |
| 2019 | 0.784 |
| 2018 | 0.710 |
| 2017 | 0.738 |
| 2016 | 0.707 |
| 2015 | 0.818 |
| 2014 | 0.783 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 8649 |
| 2021 | 9067 |
| 2020 | 7459 |
| 2019 | 6068 |
| 2018 | 6754 |
| 2017 | 6369 |
| 2016 | 6685 |
| 2015 | 5757 |
| 2014 | 5862 |
Expert Review of Pharmacoeconomics and Outcomes Research is published by Taylor and Francis Ltd.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2001-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Expert Review of Pharmacoeconomics and Outcomes Research is Expert Rev. Pharmacoeconomics Outcomes Res.. This abbreviation ('Expert Rev. Pharmacoeconomics Outcomes Res.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Expert Review of Pharmacoeconomics and Outcomes Research latest impact IF is 2.48. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 2.48 (2022) and 1.61 (2016), respectively, in the last 9 years. Moreover, its average IS is 1.92 in the previous 9 years.
The Expert Review of Pharmacoeconomics and Outcomes Research has an SJR (SCImago Journal Rank) of 0.596, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.818 in 2015 and the lowest being 0.552 in 2021. Furthermore, the average SJR of the Expert Review of Pharmacoeconomics and Outcomes Research over the previous 9-year period stands at 1.92.
The latest h-index of the Expert Review of Pharmacoeconomics and Outcomes Research is 60.
The Expert Review of Pharmacoeconomics and Outcomes Research is published by the Taylor and Francis Ltd., with its country of publication being the United Kingdom.
The Expert Review of Pharmacoeconomics and Outcomes Research is currently ranked 8649 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 5757 in 2015 and its lowest position of 9067 in 2021.
The standard ISO4 abbreviation for the Expert Review of Pharmacoeconomics and Outcomes Research is Expert Rev. Pharmacoeconomics Outcomes Res..
Expert Review of Pharmacoeconomics and Outcomes Research is classified as a journal that the Taylor and Francis Ltd. publishes.
The Expert Review of Pharmacoeconomics and Outcomes Research encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Expert Review of Pharmacoeconomics and Outcomes Research is assigned the following International Standard Serial Numbers (ISSN): 14737167, 17448379.
The best quartile for the Expert Review of Pharmacoeconomics and Outcomes Research is Q2 (2022).
The Expert Review of Pharmacoeconomics and Outcomes Research coverage history can be summarized as follows: 2001-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Indian Journal of Plastic Surgery | journal | 16018 | Thieme Medical Publishers Inc. | 37 | 0.65 |
| European Union Politics | journal | 2250 | SAGE Publications Ltd | 72 | 2.64 |
| Historia | journal | 27560 | Universidade Estadual Paulista | 7 | 0.02 |
| SPE Production and Operations Symposium, Proceedings | conference and proceedings | 15907 | 21 | 0.00 | |
| Entrepreneurship Theory and Practice | journal | 338 | Wiley-Blackwell | 185 | 12.75 |
| Journal of Classical Sociology | journal | 13766 | SAGE Publications Ltd | 27 | 0.83 |
| International Journal of Applied Linguistics | journal | 7321 | Wiley-Blackwell Publishing Ltd | 51 | 2.00 |
| Canadian Journal of Education | journal | 17961 | Canadian Society for the Study of Education (CSSE) | 41 | 0.39 |
| Journal, Indian Academy of Clinical Medicine | journal | 24608 | Indian Academy of Clinical Medicine | 16 | 0.06 |
| Journal of Sociolinguistics | journal | 5409 | Wiley-Blackwell Publishing Ltd | 61 | 1.96 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 2.48 |
| 2021 | 2.08 |
| 2020 | 1.87 |
| 2019 | 2.11 |
| 2018 | 1.71 |
| 2017 | 1.65 |
| 2016 | 1.61 |
| 2015 | 1.80 |
| 2014 | 1.96 |
